4 / 12
International Journal of Anesthesiology & Pain Medicine
ISSN: 2471-982X
Volume 4
March 26-28, 2018
Vienna, Austria
Pain Management 2018
Internal Medicine 2018
Page 20
JOINT EVENT
7
t h
E d i t i o n o f I n t e r n a t i o n a l C o n f e r e n c e o n
Internal Medicine and Patient Care
&
6
t h
E d i t i o n o f I n t e r n a t i o n a l C o n f e r e n c e o n
Pain Management
A
new systems approach to diseased states and wellness
result in a new branch in the healthcare services, namely,
personalized medicine (PM). To achieve the implementa-tion of
PM concept into the daily practice including clinical cardiology,
it is necessary to create a fundamentally new strategy based
upon the subclinical recognition of bioindicators (biopredictors
and biomarkers) of hidden abnormalities long before the
disease clinically manifests itself. Each decision-maker values
the impact of their decision to use PM on their own budget and
well-being, whichmay not necessarily be optimal for society as a
whole. It would be extremely useful to integrate data harvesting
from different databanks for applications such as prediction
and personalization of further treatment to thus provide more
tailored measures for the patients and persons-at-risk resulting
in improved outcomes whilst securing the healthy state and
wellness, reduced adverse events, and more cost effective
use of health care resources. One of the most advanced
areas in cardiology is atherosclerosis, cardiovascular and
coronary disorders as well as in myocarditis. A lack of medical
guidelines has been identified by the majority of responders as
the predominant barrier for adoption, indicating a need for the
development of best practices and guidelines to support the
implementation of PM into the daily practice of cardiologists!
Implementation of PM requires a lot before the current model
“physician-patient” could be gradually displaced by a newmodel
“medical advisor-healthy person-at-risk”. This is the reason for
developing global sci-entific, clinical, social, and educational pro-
jects in the area of PM to elicit the content of the new branch.
Biography
Sergey Suchkov graduated from Astrakhan State Medical University and
was awarded with MD and maintained his PhD and Doctor’s degree. He
was working for Helmholtz Eye Research Institute and Moscow Region-
al Clinical Research Institute. He was a Secretary-in-Chief of the Editorial
Board,
Biomedical Science,
an international journal published jointly by
the USSR Academy of Sciences and the Royal Society of Chemistry, UK.
Currently, he is a Director of Center for Personalized Medicine, Sechenov
University; Chair of the Department for Translational Medicine, Moscow
Engineering Physics University and Secretary General of United Cultural
Convention, Cambridge, UK. He is a Member of the New York Academy of
Sciences; American Chemical Society; American Heart Association; AMEE,
Dundee, UK; EPMA, Brussels, EU; PMC, Washington, DC, USA and ISPM,
Tokyo, Japan.
ssuchkov57@gmail.comPersonalized and translational medicine as a
model of the healthcare services and arma-
mentarium to get the model armed: myth or
the reality?
Sergey Suchkov
I M Sechenov First Moscow State Medical University and Moscow Engineering Physical
Insti-tute (MEPhI), Russia
Sergey Suchkov, Int J Anesth Pain Med 2018, Volume 4
DOI: 10.21767/2471-982X-C1-001